19.1.34 NRx Enhancements

___________________________________________________________________________________________________________________________________________________________________________

 

Important Notice

 

Welcome to your new Help Guide experience! In response to Adobe ending its support of Adobe Flash on December 31, 2020, we have migrated to HTML5. We really hope you enjoy the new look and feel of Help. Thank you!

 

With you in mind, we're striving to improve the look and usability of Help. While we take actions to enhance your experience, you'll notice format and layout changes to new and existing topics. Over time, we hope you'll enjoy these improvements. As always, thank you for visiting!

___________________________________________________________________________________________________________________________________________________________________________

 

Here's What's New in NRx:

 

Cancel RxRequests

 

Diagnosis on RxRenewal Response

 

Diagnosis on Rx Transfer

 

Increased SIG on RxRenewal Request

 

HL7 Dispensing Field Additions

 

Tax Schedules

 

Notification of Vaccination

 

Drug Interaction Drug Scan Access

 

Drug Vendor Rebate on ACQ Pricing

 

Electronic Prescription Printout Copy

 

New Format Option for RxRenewal Request Printout

 

PMP Consult

 

14-Day Psychotropic Prompt for Profiled Prescriptions

 

Restrict Transaction Changes After Adjudication

 

De-identification of HIPAA on Patient Monographs

 

Lock NDC After Tote Closed

 

Send Date Sold to PMP

 

ASAP 4.2B Compliancy for 2021

 

Electronic Sidebar

 

AR Detail Export

 

Updated Expiration on CMS Notice Printout

 

CA CURES

 

RedSail Patient Chart

 

Reason Code for Partially Dispensed Medications

 

Track and Trace

 

___________________________________________________________________________________________________________________________________________________________________________

 

Help Guide Tips:

 

Help Guide Search

 

Return to Homescreen from Topics

___________________________________________________________________________________________________________________________________________________________________________

 

 

 

Return to What's New